Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Eosinophil count procedure
|
1144 | 0.683 | 0.360 | 10 | 113588287 | missense variant | G/A | snv | 2.2E-02 | 2.4E-02 | 0.700 | 1.000 | 2 | 2016 | 2019 | ||||
Blood Protein Measurement
|
2575 | 0.683 | 0.360 | 10 | 113588287 | missense variant | G/A | snv | 2.2E-02 | 2.4E-02 | 0.700 | 1.000 | 1 | 2018 | 2018 | ||||
Cardiac troponin I measurement
|
14 | 0.683 | 0.360 | 10 | 113588287 | missense variant | G/A | snv | 2.2E-02 | 2.4E-02 | 0.700 | 1.000 | 1 | 2019 | 2019 | ||||
THYROID CANCER, NONMEDULLARY, 5
|
1 | 0.683 | 0.360 | 10 | 113588287 | missense variant | G/A | snv | 2.2E-02 | 2.4E-02 | 0.700 | 0 | |||||||
Familial Nonmedullary Thyroid Gland Carcinoma
|
6 | 0.683 | 0.360 | 10 | 113588287 | missense variant | G/A | snv | 2.2E-02 | 2.4E-02 | 0.040 | 1.000 | 4 | 2016 | 2018 | ||||
Malignant neoplasm of thyroid
|
103 | 0.683 | 0.360 | 10 | 113588287 | missense variant | G/A | snv | 2.2E-02 | 2.4E-02 | 0.040 | 1.000 | 4 | 2016 | 2017 | ||||
Papillary thyroid carcinoma
|
204 | 0.683 | 0.360 | 10 | 113588287 | missense variant | G/A | snv | 2.2E-02 | 2.4E-02 | 0.040 | 1.000 | 4 | 2016 | 2018 | ||||
Thyroid carcinoma
|
145 | 0.683 | 0.360 | 10 | 113588287 | missense variant | G/A | snv | 2.2E-02 | 2.4E-02 | 0.040 | 1.000 | 4 | 2016 | 2017 | ||||
Thyroid Neoplasm
|
135 | 0.683 | 0.360 | 10 | 113588287 | missense variant | G/A | snv | 2.2E-02 | 2.4E-02 | 0.040 | 1.000 | 4 | 2016 | 2017 | ||||
Fibrosis, Liver
|
64 | 0.683 | 0.360 | 10 | 113588287 | missense variant | G/A | snv | 2.2E-02 | 2.4E-02 | 0.030 | 1.000 | 3 | 2009 | 2016 | ||||
familial non-medullary thyroid cancer
|
1 | 0.683 | 0.360 | 10 | 113588287 | missense variant | G/A | snv | 2.2E-02 | 2.4E-02 | 0.020 | 0.500 | 2 | 2017 | 2017 | ||||
Familial Nonmedullary Thyroid Cancer
|
2 | 0.683 | 0.360 | 10 | 113588287 | missense variant | G/A | snv | 2.2E-02 | 2.4E-02 | 0.020 | 1.000 | 2 | 2016 | 2017 | ||||
Neoplasms
|
1644 | 0.683 | 0.360 | 10 | 113588287 | missense variant | G/A | snv | 2.2E-02 | 2.4E-02 | 0.020 | 1.000 | 2 | 2016 | 2017 | ||||
Atherothrombosis
|
15 | 0.683 | 0.360 | 10 | 113588287 | missense variant | G/A | snv | 2.2E-02 | 2.4E-02 | 0.010 | 1.000 | 1 | 2008 | 2008 | ||||
Breast Carcinoma
|
2793 | 0.683 | 0.360 | 10 | 113588287 | missense variant | G/A | snv | 2.2E-02 | 2.4E-02 | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||
Cardiovascular Diseases
|
711 | 0.683 | 0.360 | 10 | 113588287 | missense variant | G/A | snv | 2.2E-02 | 2.4E-02 | 0.010 | 1.000 | 1 | 2006 | 2006 | ||||
Carotid Stenosis
|
19 | 0.683 | 0.360 | 10 | 113588287 | missense variant | G/A | snv | 2.2E-02 | 2.4E-02 | 0.010 | 1.000 | 1 | 2006 | 2006 | ||||
Cirrhosis
|
110 | 0.683 | 0.360 | 10 | 113588287 | missense variant | G/A | snv | 2.2E-02 | 2.4E-02 | 0.010 | 1.000 | 1 | 2009 | 2009 | ||||
Deep Vein Thrombosis
|
93 | 0.683 | 0.360 | 10 | 113588287 | missense variant | G/A | snv | 2.2E-02 | 2.4E-02 | 0.010 | 1.000 | 1 | 2008 | 2008 | ||||
Diabetes
|
710 | 0.683 | 0.360 | 10 | 113588287 | missense variant | G/A | snv | 2.2E-02 | 2.4E-02 | 0.010 | 1.000 | 1 | 2009 | 2009 | ||||
Diabetes Mellitus
|
824 | 0.683 | 0.360 | 10 | 113588287 | missense variant | G/A | snv | 2.2E-02 | 2.4E-02 | 0.010 | 1.000 | 1 | 2009 | 2009 | ||||
Familial (FPAH)
|
276 | 0.683 | 0.360 | 10 | 113588287 | missense variant | G/A | snv | 2.2E-02 | 2.4E-02 | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||
Hepatitis C
|
347 | 0.683 | 0.360 | 10 | 113588287 | missense variant | G/A | snv | 2.2E-02 | 2.4E-02 | 0.010 | 1.000 | 1 | 2009 | 2009 | ||||
Liver Cirrhosis
|
189 | 0.683 | 0.360 | 10 | 113588287 | missense variant | G/A | snv | 2.2E-02 | 2.4E-02 | 0.010 | 1.000 | 1 | 2009 | 2009 | ||||
Malignant neoplasm of breast
|
3417 | 0.683 | 0.360 | 10 | 113588287 | missense variant | G/A | snv | 2.2E-02 | 2.4E-02 | 0.010 | 1.000 | 1 | 2017 | 2017 |